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Abstract 
 
As one of the most abundant toxic contaminants in the atmosphere, carbon monoxide (CO) plays 
a significant role in toxicology and public health. Every year around half of the accidental non-
fire related poisoning deaths are attributed to CO in the US, UK and many other countries. 
However, due to the non-specificity of the symptoms and often encountered inconsistency of 
these with the results obtained from measurements of the biomarker for CO poisonings, 
carboxyhaemoglobincarboxyhemoglobin (COHb), there is a high rate of misdiagnoses. The 
mechanism of toxicity of CO includes not only the reduced transport of oxygen caused by 
COHb, but also the impairment of cellular respiration and activation of oxidative metabolism by 
binding to other proteins.  
Therefore, in this study we propose the measurement of the total amount of CO in blood (TBCO) 
by Airtight Gas Syringe-Gas Chromatography-Mass Spectrometry (AGS-GC-MS) as an 
alternative to COHb for the determination of CO exposures. The method is validated for a 
clinical range with TBCO concentrations of 1.63-104 nmol/mL of headspace (HS) (0.65-41.6 
µmol/mL blood). The limit of quantification (LOQ) was found between 2 and 5 nmol/mL HS 
(0.8 and 2 µmol/mL blood). The method is applied to a cohort of 13 patients, who were exposed 
to CO under controlled conditions, and results compared to those obtained by CO-oximetry. 
Furthermore, samples were compared before and after a “flushing” step to remove excess CO.  
Results showed a significant decrease of TBCO when samples were flushed (10-60%), whereas 
no constant trend was observed for COHb. Therefore, measurement of TBCO by AGS-GC-MS 
suggests the presence of more dissolved CO than previously known. This constitutes a first step 
into the acknowledgment of a possibly significant amount of CO present not in form of COHb, 
but as free CO, which might help explain the incongruences with symptoms and decrease 
misdiagnoses.   
 
Keywords: carbon monoxide exposure; carbon monoxide determination; CO rebreathing; blood 
analysis; flushing; GC-MS; biomarker; 
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1. Introduction 
 
Carbon monoxide (CO) is a highly toxic gas produced through incomplete combustion of 
hydrocarbon-based materials and fuels. It is one of the most abundant air pollutants, hence every 
individual is exposed to it on a daily basis through the innate and essential act of breathing. 
However, CO in small amounts is also produced endogenously, mainly through catalysis of 
heme and heme-containing proteins and through processes such as lipid peroxidation and 
photooxidation. Therefore, very low levels of CO are present in each individual, even though 
levels can vary according to physiological as well as pathological conditions [1]. The burden of 
CO in air varies according to the amount and type of CO sources present in the living or working 
area of an individual, the season, which determines whether there are higher number of fires and 
barbecues (summer) or a high use of wood- or fuel-fired stoves and heaters (winter), and whether 
the individual is a smoker or exposed to passive smoke. Typically, CO concentrations in indoor 
air are below 30 ppm, they are around double the amount in outdoor air [2]. Even though the 
World Health Organization (WHO) and the national health and safety institutions of most 
countries have clear guidelines on the tolerance limits for CO exposure [3-5], carbon monoxide 
poisoning is the main cause of accidental non-fire related poisoning deaths in western countries 
[6, 7] and leads to a high number of emergency department (ED) admissions worldwide [6-16]. 
However, these numbers of fatalities and ED admissions likely underestimate the real burden of 
CO on the population. This is due to the characteristics of CO and the clinical, non-specific 
symptoms of CO intoxication. CO is an odorless, tasteless and colorless gas, making it difficult 
to detect if above normal concentrations and without the appropriate measuring devices [17]. 
Clinical diagnosis of CO poisoning is difficult due to the non-specific symptoms it presents: 
dizziness, nausea, fatigue, headaches [18]; often the causes of CO poisonings are misdiagnosed 
and attributed to other diseases or disturbances [19]. Misdiagnoses can also arise from errors due 
to the analytical measurement techniques and parameters used (measurement error) and the 
related incongruence with symptoms reported by patients [19-23].  
The current biomarker for CO exposure is carboxyhaemoglobincarboxyhemoglobin (COHb). 
Once CO enters the bloodstream, it binds to hemoglobin (Hb) competitively to oxygen (O2) [24, 
25]. This very high affinity of CO for Hb (200-250 times higher than O2) causes a strong bond 
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between CO and Hb and leads to the inhibition of oxygen transport through Hb and delivery to 
tissues, also a suggested mechanism for the resulting hypoxia in brain and heart, primary 
consequences of CO exposure [3]. However, the presence of CO in blood only in form of COHb 
does not explain the inconsistency repeatedly reported between COHb% results and symptoms 
[26]. One hypothesis, suggested in previous studies [23, 27], is that a random and possibly 
significant amount of CO in blood is not bound to Hb, but is present in free form and can thus 
distribute to other tissues, hasleading to pathophysiological relevance effects through direct 
cellular toxicity. Around 10-15% of the absorbed CO has been previously documented to bind to 
proteins other than Hb [28, 29]. These other proteins include myoglobin, cytochromes and 
guanylyl cyclase. Binding to myoglobin reduces the availability of oxygen in the heart and may 
lead to arrhythmias and cardiac dysfunctions as well as causing direct toxicity of skeletal muscle 
[30]. CO binding to mitochondrial cytochrome oxidase, which was reported for in vitro studies 
[31, 32], impairs cellular respiration by inactivation of mitochondrial enzymes and also initiates 
an oxidative metabolism by generating oxygen free radicals [29, 30, 33]. Even though the 
affinity of CO for cytochrome oxidase is relatively low, the dissociation is very slow, leading to 
a prolonged impairment of oxidative metabolism, which may help explain the tardive and 
sustained effects of CO toxicity even after COHb has been cleared from the system through 
hyper- or normobaric oxygen therapy [28, 29]. The loss of consciousness associated with CO 
poisoning may be caused by the stimulation of guanylyl cyclase, since increases in cyclic 
guanosine monophosphate (cGMP) result in cerebral vasodilation [34, 35].          
In general, the role of direct cellular CO toxicity seems to be underestimated in the prevailing 
CO poisoning literature, given that most studies date back several decades. But given the 
numerous pathophysiological mechanisms, it is important to be able to determine the total 
amount of CO and not only COHb in CO poisoning cases.     
However, current measurement methods are based on COHb, either through spectrophotometric 
techniques, such as UV-spectrophotometry and CO-oximetry [36-41], or gas chromatographic 
techniques, such as Gas Chromatography-mass spectrometry (GC-MS) or GC-Flame Ionization 
Detection (GC-FID) [1, 42-48], where the CO measured is backcalculated and correlated to 
COHb. The issue with optical methods is the dependency of the technique on the quality of the 
sample. Alterations of the sample, which can occur through degradation due to a time-delayed 
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analysis or/and unsatisfactory and uncontrolled storage conditions [39, 45, 49-53], make the 
optical analysis difficult to interpret or in some cases infeasible. Gas chromatographic methods 
can overcome these problems in most cases. The CO present in blood is released through a 
releasing agent and then analysed either directly (GC-MS) [42, 44-46] or after transformation 
into methane (GC-FID) [47, 54-57] in its gaseous form. One important step that has been applied 
in previous studies includes the “flushing” of the calibrator in order to target only CO bound to 
Hb. To achieve that, blood is subjected to a stream of nitrogen gas for an amount of time, to 
remove all excess CO [45, 47, 48, 52, 55, 56, 58] and, therefore, this approach does not consider 
the amount of excess CO as relevant, but only that bound to Hb. This could lead to mis- or 
underestimation of the total load of CO in blood. For this reason, in a previous study an approach 
that is based on the measurement of the total amount of CO in blood (TBCO) by airtight gas 
syringe(AGS)-GC-MS was developed and validated, however only for a concentration range 
with postmortem application [23].   
With this research, we aim to test the hypothesis of the presence of CO in free form in blood, by 
comparing analysis results of flushed and unflushed blood samples obtained at bedside from 
patients that were exposed to CO. This represents the first step in expanding the knowledge of 
the true CO burden. Furthermore, we want to improve the TBCO measurement technique by 
validating it for a concentration range applicable also in clinical settings.                        
 
2. Materials and Methods 
 
2.1 Chemicals and reagents 
 
Formic acid (reagent grade, purity ≥95%) was purchased from Sigma-Aldrich (St Louis, USA) 
and CO gas (99%) was from Multigas (Domdidier, Switzerland). To prevent degradation all 
formic acid solutions were prepared on a daily basis. The internal standard formic acid (13C, 
99%) was ordered from Cambridge Isotope Laboratories (Cambridge, UK). Sulfuric acid 
(≥97.5%) was purchased from Fluka (Buchs, Switzerland). Human blood samples were obtained 
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from volunteers participating in a study at the Department of Nephrology of the University 
Hospital of Geneva (HUG) in Switzerland. Blood of non-smokers before exposure to CO was 
used as blank matrix. For the in vitro study of CO fortified blood, bovine blood was obtained 
from a local butcher.     
 
2.2 Materials 
 
The AVOXimeter 4000 Whole Blood CO-Oximeter and cuvettes were obtained from 
International Technidyne Corporation - ITC (Edison, USA). S-Monovettes of following types: 
2.6mL K3E (Ethylenediaminetetraaceticacid, EDTA), 3mL 9NC (sodium citrate, NaCit), 2.7mL 
FE (sodium fluoride, NaF), 2.6mL KH (lithium heparin, LiH), were obtained from Sarstedt 
(Nürnbrecht, Germany). Precision sampling gas syringes equipped with a press button valve and 
with capacities of 500µL (for dilution) and 2mL (for injection) were purchased from VICI 
(Baton Rouge, LA, USA). Aluminum caps were from Milian (Vernier, Switzerland). All 
extractions were carried out in 20mL headspace vials from Agilent Technologies (Santa Clara, 
CA, USA).  
 
2.3 Instruments and GC-MS conditions   
 
AVOXimeter 4000 Whole Blood CO-Oximeter from ITC was used for all COHb analyses. The 
instrument uses five wavelengths for quantitative analysis, namely 520.1, 562.4, 585.2, 597.5 
and 671.7 nm. Following parameters can be measured: total hemoglobin (tHb), oxyhemoglobin 
(O2Hb), COHb and Methemoglobin (MetHb). In this study, Mmanufacturer guidelines were 
followed to obtain COHb concentrations [59, 60].   
Agilent 6890 N GC (Palo Alto, USA) equipped with a HP Molecular Sieve 5 Å PLOT capillary 
column (30 m x 0.32 mm x 30µm) purchased from Restek (Bellefonte, USA) was used for gas 
chromatographic analysis. The temperature program used was as follows: 50°C, held for 4 
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minutes; injector temperature was set at 180°C, the injector used in splitless mode, and the MS 
interface at 230°C. Helium was employed as carrier gas, at a flow rate of 40.0 mL/min. A solvent 
delay of 1.8 minutes was introduced.  
An Agilent 5973 mass spectrometer (Palo Alto, USA) was used for detection, operating in 
electron ionization (EI) mode at 70eV. Selected Ion Monitoring (SIM) mode was used to acquire 
the signal for CO at m/z 28 and 13CO at m/z 29, both at the same retention time of 3.5 min. 
 
2.4 Sample preparation 
 
2.4.1 Calibration standards  
An aliquot of human blood from non-smokers, which was previously controlled by CO-oximetry 
and found at 0% COHb, is used as matrix for calibration. Calibration standard working solutions 
of formic acid (43 µmol/mL) and working solutions of the internal standard isotopically labelled 
formic acid (84 µmol/mL) were prepared daily de novo in order to prevent degradation. 
Calibration points were set in a working range between 0-104 nmol/mL HS, with points at 1.63, 
3.25, 6.5, 13, 26, 52 and 104 nmol/mL HS (equivalent to 0.65, 1.3, 2.6, 5.2, 10.4, 20.8 and 41.6 
µmol/mL in blood). Matrix effects were evaluated by preparing a blank sample with the matrix 
without any reagent. 10 µL of the working internal standard solution were added to each 
calibration sample before extraction, leading to a final concentration of 42 nmol of 13CO/mL HS. 
All standards and samples were stored at +4°C when not in use.   
 
2.4.2 Quality controls (QC) 
QC were performed with five internal control samples, at concentrations of 2, 5, 10, 30 and 60 
nmol/mL HS (0.8, 2, 4, 12 and 24 µmol/mL blood), which were prepared daily with formic acid 
obtained from a different lot diluted with deionized water.  
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Additionally, validity of the method was tested with external controls, which were prepared by 
dilution of pure CO gas at two concentration levels, low and high, respectively 5 and 60 
nmol/mL HS.     
 
2.4.3 Extraction procedure 
100µL aliquots of blood were introduced in a 20mL HS-vial, followed by 10µL of the internal 
standard solution. For calibration points, the respective aliquots of formic acid solution were 
added. Aluminum caps of 11mm (i.d.) were first filled with 100µL sulfuric acid and then 
carefully introduced into the HS-vial. The vial was immediately hermetically sealed with 
PTFE/silicone septum caps of 20 mm (i.d.). In order to ensure complete mixing of the liquids 
contained in the vial, the samples were vigorously shaken and vortexed. Extraction was finalized 
by heating the vials at 100°C for 60 minutes.  
     
2.5 Analysis procedure 
 
2.5.1 CO-oximeter 
Approximately 50-100µL of blood were sampled from the sampling tube and placed into an 
Avoximeter 4000 Whole Blood CO-oximeter cuvette, which was then introduced in the 
Avoximeter 4000 Whole Blood CO-oximeter for analysis.  
 
2.5.2 CO in blood 
1mL HS was sampled from the 20mL HS-vial containing the extract and injected in the GC-MS 
for analysis.  
To ensure that no contamination from CO contained in the air affected the measurements 
occurred, a 1mL aliquot of air in the analysis-room was additionally analysed prior to sample 
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analyses. Air samples were collected with the AGS and analysed by GC-MS with the same 
conditions as the blood samples.       
 
2.6  Validation procedure  
 
The validation was performed according to the guidelines of the “French Society of 
Pharmaceutical Sciences and Techniques” (SFSTP) [61] and included following validation 
parameters: response function (calibration curve), linearity, selectivity, trueness, precision 
(repeatability and intermediate precision), accuracy, limit of detection (LOD) and limit of 
quantification (LOQ). 
The response function, also defined as the calibration curve, is described as the relationship 
between the concentration of the analyte in the sample and the corresponding instrument 
response.  
Linearity of the method is assessed by fitting backcalculated concentrations of control samples 
against the theoretical concentrations through application of the linear regression model and 
evaluating the resulting regression coefficient.  
Trueness, also defined as bias, describes the closeness between the average of the experimental 
value and the calculated target value. It is expressed as percent deviation from the calculated 
target value.  
Precision is defined as closeness of agreement (degree of scatter) between a measurement series 
obtained from multiple sampling of the same homogenous sample under the prescribed 
conditions and is determined by calculating the repeatability (intra-day precision) and 
intermediate precision (inter-day precision) for each control sample. The repeatability is 
determined by calculating the intra-day variance (S2r) and the intermediate precision through the 
sum of intra- and inter-day variances (S2IP).  
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Accuracy describes the closeness of agreement between the conventional true value or an 
accepted reference value and the value experimentally found. It is expressed as the sum of 
trueness (systematic error) and precision (random error).   
Calibrators and QCs were used for the validation experiments performed on three non-
consecutive days (p=3) not within the same week. The validation approach is based on the use of 
a β-expectation interval tolerance of 80%, indicating that the intervals for each experimental 
point include an average of 80% of the total values. The tolerance intervals (TI) were defined as 
TI = X ± k × √ (S2r + S
2
R), where S
2
r is the standard deviation of repeatability and S
2
R is the 
standard deviation of reproducibility. In the β-expectation interval tolerance approach, k = tᵥ × 
√(1 + [1 / (I × J × B2)]), where I is number of series, J is the number of repetitions, and B2 is a 
coefficient. This coefficient is given as B2 = (R + 1) / [J × (R + 1)] with R = S2r / S
2
R. tᵥ is 
Student’s coefficient with degrees of freedom ν defined as ν = (R + 1)2 / {[(R + 1 / J)2 / (I – 1)] + 
[(1 - 1/J) / (I × J)]}.    
 
2.7 Samples from volunteers 
 
2.7.1 CO-rebreathing method 
The CO-rebreathing method consists of a closed-circuit breathing system containing oxygen 
mixed with a certain amount of carbon monoxide. Patients breathe in and out through a 
mouthpiece linked to the circuit. In the study from which we acquired the blood samples, 
patients were lying in horizontal position. After insertion of the mouthpiece, an adjustment 
period of 2 minutes was used to deliver O2 only, before starting the delivery of the O2-CO 
mixture for a period of 10 minutes [62]. The volumes of CO delivered in O2 were between 57 
and 105 mL, calculated according to the body mass index of each volunteer, in order to reach a 
target COHb value of approximately 10%.   
 
2.7.2 Blood collection and preparation 
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Blood samples were obtained from a cohort of 13 patients (9 men, 4 women) under treatment at 
the Nephrology Department of the University Hospital in Geneva (HUG), Switzerland.  
Three blood samples were taken from volunteers, one before and two directly after exposure to 
CO. Samples were immediately analysed by CO-oximetry. Half of the samples taken after 
exposure of the individual to CO were flushed with a nitrogen stream for 2 minutes, with a flow 
rate below 5 mL/min. Two needles were inserted in the rubber septum of the blood tube. One 
needle was plunged in blood and provided the nitrogen stream whereas the other was placed in 
the HS of the blood tube in order to relieve the pressure in the blood tube built with the release of 
CO and the nitrogen flush. After flushing, the samples were analysed by CO-oximetry. 
Simultaneously, all samples (before exposure, flushed and not flushed after exposure) were 
prepared for analysis with AGS-GC-MS and analysed in triplicates. All sampling and testing 
performed on volunteers was approved by ethical committee under the study number CCER-
2017-00421.        
 
2.8 In vitro study of CO fortified samples 
 
To test the relevance of the validated clinical range of CO concentrations for the blood samples 
obtained from the volunteers, in vitro CO-fortified blood samples were prepared. Bovine blood 
was obtained freshly from a local butcher and immediately transferred in containers with 
anticoagulants (EDTA, LiH, NaF, NaCit) to avoid coagulation during transport to the laboratory. 
After arrival at the laboratory, CO-oximetric analyses of the blood were performed to confirm 
the baseline CO-content. Fortification with pure CO gas was then carried out by bubbling the gas 
directly into the blood for varying amounts of time. The COHb saturation levels were checked in 
10-minute-intervals with the CO-oximeter until the desired initial COHb% level was reached. To 
ensure homogenization, the bottles were agitated for 20 minutes after fortification and the final 
COHb concentration was subsequently measured. After reaching of the designated COHb%-
saturation (10-20%, 30-40% and 60-70%), blood was transferred to the sampling tubes and 
subsequently analysed without any flushing, in order to respect the physiological conditions of 
blood sampling and analysis when an individual is suspected of a CO poisoning.   
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2.9 Statistical analyses 
 
Mean, standard deviation and interquartile ranges were determined for all measured variables. 
Paired student t-test with a α-error of 0.05 was performed for comparison of the group means. 
All data treatment and statistical analyses were performed with R (version 3.3.1, 2016-06-21).    
 
 
3. Results  
 
3.1 Validation of the method in a clinical range 
 
Results of the validation for all criteria are summarized in Table 1.  
Calibration curves for CO determination were obtained by using CO negative human blood as 
blank matrix. Calibration curves, which represent the response function, were acquired on three 
non-consecutive days (p = 3), in triplicates (n = 3) and at seven concentration levels (k = 7): 1.63, 
3.25, 6.5, 13, 26, 52 and 104 nmol/mL HS (equivalent to 0.65, 1.3, 2.6, 5.2, 10.4, 20.8 and 41.6 
µmol/mL blood). For each calibration point, calculated concentrations were compared to the 
target values and found to be within ± 20%. The relationship between the CO concentration from 
samples spiked with formic acid and the measured response was found to be linear. Validation 
coefficients for the calibration curves are shown in Table 1(I).    
On each non-consecutive day (p = 3), control samples at five different concentrations (k = 5), 
namely 2, 5, 10, 30 and 60 nmol/mL HS (0.8, 2, 4, 12 and 24 µmol/mL blood), were measured in 
triplicates (n = 3). The concentrations of the control samples were calculated by using the 
calibration curve determined for each analysis day. As shown in Table 1(II), a satisfactory 
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linearity was obtained, with a slope of 1.05 and a regression coefficient of 0.99 in the range of 2 
to 60 nmol/mL HS (0.8-24 µmol/mL blood).    
Selectivity of the AGS-GC-MS method was previously confirmed in the work by Oliverio et al., 
hence was not repeated in this study [22].    
Trueness was found to be lower than the acceptance criteria (within ±20% of the accepted 
reference value and within 20% at the LOQ), as is shown in table 1(III), which is satisfactory for 
CO determinationvalidation according to SFSTP guidelines [61].  
Table 1(IV) shows that the relative standard deviation (RSD) for repeatability and intermediate 
precision are in a range between 0.50% and 3.55%.    
Figure 1 represents the accuracy profile for CO. The mean bias (%) confidence interval limits for 
the control samples were within the acceptability limits of ±30%. Taking into consideration the 
acceptability limits of ±30%, the limit of quantification within validation criteria was found 
between 2 and 5 nmol/mL HS (0,8 and 2 µmol/mL blood). Thus, the method is confirmed to be 
accurate within the range of 5 and 60 nmol/mL HS (2-24 µmol/mL blood) according to the β-
interval tolerance accuracy profile.   
In addition, the external controls gave an excellent accuracy, with an RSD below 15% (Table 1 
(V)). 
 
3.2 Analyses of flushed samples 
 
Blood samples of 13 patients were analysed before and after exposure to CO as well as with and 
without a flushing step. Triplicates were acquired for analyses with CO-oximetry and AGS-GC-
MS. Results of all analyses are found in Table 2 and represented in Figure 2.  
For all samples analysed, a relative increase of both TBCO and COHb can be observed when 
comparing the values before and after CO exposure (Figure 2 and Table 2). Increases were 
confirmed and found to be significant by comparing the means with Student t-Test (Table 3). 
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Important observations can be made when comparing the COHb and TBCO levels before and 
after a flushing step (Table 2 and 3). For the levels of COHb there is no consistent trend that can 
be observed, with a COHb increase in some patients and a decrease in others. The 25th and 75th 
interquartile range (Table 3) for COHb before and after flushing (range includes 0) as well as the 
results of the t-Test (p-Value > 0.05) confirm this result. This behavior could be explained by the 
known analytical variability of CO-oximeters at such low COHb saturations [63, 64]. 
Conversely, TBCO shows a consistent trend: for all samples analysed, TBCO before flushing is 
higher than after flushing. Statistical significance was confirmed by performing a paired Student 
t-Test of the means (p-Value = 8.955e-06). Mean and interquartile range for TBCO differences 
before and after flushing additionally confirm the positive relationship (Table 3).    
 
4. Discussion 
 
An improved AGS-GC-MS method for CO determination in blood was validated for a clinical 
concentration range (1.63-104 nmol/mL HS / 0.65-41.6 µmol/mL blood) and was successfully 
applied to the analysis of blood samples coming from individuals with controlled CO exposures. 
The observed increase of both COHb and TBCO before and after CO exposure was to be 
expected, since all individuals were breathing in a mixture of O2 and CO. Patients with a CO 
burden before exposure, namely patients with ID number 3, 4, 9, 11, 12 and 13, admitted to be 
smokers. Smokers are known to have a higher baseline CO level, which varies depending on the 
frequency [65-67], hence it explains the presence of CO in several patients before exposure.  
A significant variability of CO burden after exposure is found between individuals. Even though 
the volumes of CO administered were adapted to the weight and height of the patients, other 
factors involving the respiratory system and blood circulation, such as ventilation rate, tidal 
volume, inspiratory and expiratory reserve volume, alveolar ventilation, cardiac rhythm and 
cardiac output, influence the net amount of CO that enters the circulation [68]. In addition, 
malfunctioning of the rebreathing system can lead to altered amounts of CO effectively being 
administered, resulting in the observed inter-patient variations.  
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The samples were all subject to the same storage and sample treatment conditions (immediately 
after blood collection) and analysed with the same parameters and measurement method (within 
48 hours after blood samplings). It is therefore not very likely that the differences in detected 
concentrations are due to any error in the measurement technique or used parameters, but mainly 
to the removal of CO through a constant nitrogen stream. This legitimizesates the hypothesis that 
there is a significant amount of CO present in free form in blood from an individual, who was 
subject to CO exposure. The amount of free CO on average ranges between 10 and 60% 
compared to the initial TBCO burden.    
Additionally, when plotting the results of the 13 clinical samples with the results obtained from 
in vitro CO-fortified samples (Figure 3), it can be seen that the clinical samples all comply with 
the in vitro measurements, further diminishing the probability of errors in the measurement and 
strengthening the assumption of CO being eliminated through flushing. This suggests that with 
the execution of a flushing step a significant amount of CO is removed from the analysed 
sample. Thus, the result is biased not only from an analytical, but also from a clinical point of 
view: the excess amount of CO may have a more significant pathophysiological activity than 
previously suspected. The direct cellular toxicity of molecular CO through impairment of 
cellular respiration and generation of free radicals, which are known to be tumor-cells promoters, 
was reported in previous studies [28, 30-35]. Yet, the importance given to its implications in the 
direct adverse effects in CO poisonings was held to a minimum. Most likely this was because the 
presence of CO dissolved in blood in free form was never clearly demonstrated before.   
Furthermore, the acknowledgment of dissolved CO represents one possible argument for 
explaining the discrepancy between reported symptoms and measured COHb. Considering only 
the amount of CO bound to Hb when determining a CO poisoning may lead to underestimation 
of the true burden CO poses, explaining why in many cases the measurements are inconsistent 
with the symptoms a patient is showing and also why several patients show symptoms with a 
certain time-delay. The amount of CO that is dissolved and not bound to Hb may be the missing 
quantity that gets closer to the true CO concentration in blood and burden on the body of an 
exposed individual. CO toxicity at cellular level may not only explain some of the symptoms of 
acute CO poisonings, but, due to the slow dissociation rate from cellular proteins, it may also 
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elucidate the reasons behind the delayed neurological effects reported hours or days after COHb 
was removed from the system through oxygen therapy and after low level chronic exposures.    
 
5. Limitations 
 
This study constitutes a preliminary study that aims to demonstrate the existence of CO dissolved 
not bound to Hb. This hypothesis has been tested with a cohort of 13 individuals through bedside 
blood collection. However, these findings have to be verified on a higher number of volunteers, 
even if the experimental design is complex to perform due to time-dependent analysis. 
Moreover, there is no clear evidence about a constant amount of CO dissolved, since in each 
patient the difference between TBCO before and after flushing varies. These variations are most 
likely due to interindividual variability: several factors such as pre-existing cardiovascular or 
respiratory conditions, metabolic rate, ventilation rate and volumes, sex and age can play a role 
in the behavior and amount of CO in blood. Additional measurements with more individuals will 
lead to higher statistical significance and will reduce the interindividual variability. In addition, 
analytical parameters affecting the storage as well as biological phenomena taking place after 
sampling of blood are known to potentially alter the measurement results, even if we reduced 
them to a minimum in this study. Further investigations into these TBCO pharmacodynamics and 
pharmacokinetics are needed to account for this behavior.   
 
6. Conclusion 
 
This study presents the validation of an improved carbon monoxide analysis method in human 
blood, based on AGS-GC-MS, for a range of 1.63 to 104 nmol/mL HS (0.65-41.6 µmol/mL 
blood), which is applicable to clinical CO exposure cases. The method was applied to a cohort of 
13 patients, who were exposed to controlled amounts of CO, and results compared to 
measurements by CO-oximetry. Furthermore, a flushing step was performed on samples after 
CO administration. Results seem to support the hypothesis that TBCO may be an alternative to 
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COHb as biomarker for determination of CO poisoning, since consideration of only CO bound to 
Hb may underestimate the total burden of CO in blood. By comparing flushed and unflushed 
samples, it was determined that there is a significant amount of CO present in blood in free form 
(10-60%) at the sampling time post-exposure.  
This represents an important finding for the understanding of the true role played by CO in 
poisoning cases and for the explanation of the discrepancy often encountered by clinicians 
between symptoms and results and the onset of delayed neurological sequaelae, even after 
complete removal of COHb from the system after normo- or hyperbaric oxygen therapy, possibly 
leading to a decrease in the number f misdiagnoses. Nevertheless, before application of the 
method in clinical settings, this hypothesis needs to be verified by more numerous cohorts and 
in-depth statistical analyses, to increase statistical power. Additionally, further investigation into 
the biochemical mechanisms behind the distribution and behavior of dissolved CO in human 
blood is required.       
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Legends for figures 
 
 
Figure 1: Accuracy profile for CO determination using a simple linear regression model within 
the range of 2-60 nmol/mL HS (0.8-24 µmol/mL blood). The continuous line represents the 
trueness (bias), the dashed lines represent the acceptance limits set at ± 30% and the dotted lines 
are the relative lower and upper accuracy limits 
Figure 2: Results for the total CO concentration in blood (TBCO) in µmol/mL (bars, left axis) 
measured by AGS-GC-MS and the COHb saturation in % (dots, right axis) measured through 
CO-oximetry in blood for 13 patients before (green) and after (blue) CO exposure and after a 
flushing step (orange).    
Figure 3: Correlation plot between TBCO in µmol/mL measured by AGS-GC-MS vs. the COHb 
saturation in % measured through CO-oximetry for two groups of samples: stored blood samples 
fortified with CO (squares for high fortification level 60-70%, lines for medium fortification 
level 30-40% and triangles for low fortification level 10-20%, n=54) and real case samples 
(circles for flushed and diamonds for not flushed samples, n=26).   
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Figure 2 
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Figure 3 
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Table 1: Validation results for CO determination in blood by AGS-GC-MS – (I) represents 
the mean coefficients of the calibration functions obtained from analysis of the calibrators; 
(II) represents the coefficients of the linear regression function obtained from analysis of the 
QCs against their theoretical value; (III) represents the trueness obtained from the QC 
analyses expressed in %; (IV) represents the precision obtained from QC analyses expressed 
in relative standard deviation % (RSD%); (V) shows mean and RSD% of the external 
controls.    
(I) Response function [1.63-104 nmol/mL HS] (k = 7, n= 3, p = 3) 
 Day 1 Day 2 Day 3 
Slope 0.03 0.02 0.03 
Intercept 0.59 0.63 0.61 
r² 0.98 0.99 0.98 
k: number of concentration levels; n: number of repetitions for each level; p: number of non-consecutive days     
(II) Linearity [2-60 nmol/mL HS] ( k = 5, n = 3, p = 3) 
Slope 1.05 
Intercept -0.48 
r² 0.99 
 
(III) Trueness (relative bias) ( k = 5, n = 3, p = 3) 
Levels [nmol/mL HS]  Trueness (%) 
2.0 -11 
5.0 -10 
10 1 
30 -18 
60 -19 
 
(IV) Precision (RSD%)  ( k = 5, n = 3, p = 3) 
Levels  [nmol/mL HS]   Repeatability and Intermediate Precision* 
2.0 0.5 
5.0 0.6 
10 1.7 
30 1.6 
60 3.6 
*Inter-series variance (s2g) is negligible for all levels, resulting in same values for repeatability and intermediate precision 
(V) External controls ( k = 2, n = 3, p = 1) 
Levels [nmol/mL HS] Mean 
(Confidence Interval) 
RSD [%] 
5 4.49 (3.93, 5.06) 12.0 
60 65.5 (60.0, 73.9) 6.57 
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Table 2: Differences in measurement results for COHb [%] and TBCO [µmol/mL] for before 
and after CO exposure and before and after flushing; for each individual, sex and volume of 
CO administered are provided.  
 
Patient 
ID 
 
Sex Volume 
CO 
[mL] 
 
COHb [%] 
 
TBCO [µmol/mL] 
 
Difference 
After-Before 
CO exposure 
Difference 
Not flushed-
flushed 
Difference 
After-Before 
CO exposure 
Difference 
Not flushed-
flushed 
1 M 84.3 1.90 -2.20 0.11 0.11 
2 M 89.0 7.30 -1.50 1.95 0.81 
3 F 87.9 7.30 -1.30 2.20 0.30 
4 M 59.3 6.80 -0.90 1.84 0.75 
5 F 48.3 5.20 0.60 0.75 0.34 
6 M 104 6.10 -0.90 0.93 0.67 
7 M 86.7 7.70 -2.60 0.74 0.33 
8 M 89.1 8.10 -0.90 1.06 0.31 
9 F 71.2 10.90 1.20 1.99 0.30 
10 M 57.4 6.80 1.50 0.78 0.66 
11 F 99.5 6.90 2.50 1.51 0.49 
12 M 60.8 6.20 2.10 1.63 0.23 
13 M 65.3 8.70 0.10 3.05 0.57 

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Table 3: Summary statistics and results of paired t-Test with 95% confidence interval (CI) 
for the differences for COHb and TBCO before (B) and after (A) exposure and before (NF) 
and after flushing (F); p-Values in bold are significant (below 0.05).   
 
 COHb Diff 
A/B [%] 
COHb Diff 
NF/F [%] 
TBCO Diff A/B 
[µmol/mL] 
TBCO Diff NF/F 
[µmol/mL] 
Mean 6.92 -0.18 1.43 0.45 
SD 2.06 1.64 0.79 0.22 
1st Quartile 6.20 -1.30 0.78 0.30 
3rd Quartile 7.70 1.20 1.95 0.66 
p-Value 6.02*e-07 0.71 2.93*e-05 8.96*e-06 
95% CI 5.98; 9.53 -1.17; 0.81 0.95; 1.90 0.32; 0.58 
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